Logo image of ELIS.PA

ELIS SA (ELIS.PA) Stock Fundamental Analysis

EPA:ELIS - Euronext Paris - Matif - FR0012435121 - Common Stock - Currency: EUR

22  +0.06 (+0.27%)

Fundamental Rating

4

ELIS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 44 industry peers in the Commercial Services & Supplies industry. While ELIS has a great profitability rating, there are quite some concerns on its financial health. ELIS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ELIS had positive earnings in the past year.
In the past year ELIS had a positive cash flow from operations.
ELIS had positive earnings in each of the past 5 years.
Each year in the past 5 years ELIS had a positive operating cash flow.
ELIS.PA Yearly Net Income VS EBIT VS OCF VS FCFELIS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

1.2 Ratios

ELIS has a better Return On Assets (2.64%) than 67.39% of its industry peers.
Looking at the Return On Equity, with a value of 7.09%, ELIS is in line with its industry, outperforming 56.52% of the companies in the same industry.
ELIS has a Return On Invested Capital (4.98%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ELIS is below the industry average of 7.74%.
The 3 year average ROIC (3.94%) for ELIS is below the current ROIC(4.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.64%
ROE 7.09%
ROIC 4.98%
ROA(3y)2.21%
ROA(5y)1.68%
ROE(3y)5.91%
ROE(5y)4.52%
ROIC(3y)3.94%
ROIC(5y)3.44%
ELIS.PA Yearly ROA, ROE, ROICELIS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4 6 8

1.3 Margins

ELIS has a better Profit Margin (5.45%) than 71.74% of its industry peers.
ELIS's Profit Margin has improved in the last couple of years.
ELIS's Operating Margin of 11.47% is amongst the best of the industry. ELIS outperforms 84.78% of its industry peers.
In the last couple of years the Operating Margin of ELIS has grown nicely.
With a Gross Margin value of 32.81%, ELIS perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
In the last couple of years the Gross Margin of ELIS has grown nicely.
Industry RankSector Rank
OM 11.47%
PM (TTM) 5.45%
GM 32.81%
OM growth 3Y22.26%
OM growth 5Y5.06%
PM growth 3Y298.56%
PM growth 5Y18.35%
GM growth 3Y3.37%
GM growth 5Y1.99%
ELIS.PA Yearly Profit, Operating, Gross MarginsELIS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELIS is destroying value.
Compared to 1 year ago, ELIS has more shares outstanding
Compared to 5 years ago, ELIS has more shares outstanding
The debt/assets ratio for ELIS has been reduced compared to a year ago.
ELIS.PA Yearly Shares OutstandingELIS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
ELIS.PA Yearly Total Debt VS Total AssetsELIS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

ELIS has an Altman-Z score of 1.31. This is a bad value and indicates that ELIS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ELIS (1.31) is comparable to the rest of the industry.
The Debt to FCF ratio of ELIS is 7.60, which is on the high side as it means it would take ELIS, 7.60 years of fcf income to pay off all of its debts.
ELIS has a Debt to FCF ratio (7.60) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.99 indicates that ELIS is somewhat dependend on debt financing.
The Debt to Equity ratio of ELIS (0.99) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 7.6
Altman-Z 1.31
ROIC/WACC0.97
WACC5.15%
ELIS.PA Yearly LT Debt VS Equity VS FCFELIS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

ELIS has a Current Ratio of 0.74. This is a bad value and indicates that ELIS is not financially healthy enough and could expect problems in meeting its short term obligations.
ELIS has a Current ratio of 0.74. This is in the lower half of the industry: ELIS underperforms 78.26% of its industry peers.
A Quick Ratio of 0.66 indicates that ELIS may have some problems paying its short term obligations.
The Quick ratio of ELIS (0.66) is worse than 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.66
ELIS.PA Yearly Current Assets VS Current LiabilitesELIS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The earnings per share for ELIS have decreased strongly by -17.13% in the last year.
ELIS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.57% yearly.
ELIS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.65%.
Measured over the past years, ELIS shows a small growth in Revenue. The Revenue has been growing by 6.58% on average per year.
EPS 1Y (TTM)-17.13%
EPS 3Y363.54%
EPS 5Y22.57%
EPS Q2Q%-13.4%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y15.37%
Revenue growth 5Y6.58%
Sales Q2Q%6.92%

3.2 Future

ELIS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.29% yearly.
The Revenue is expected to grow by 4.92% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y3.75%
EPS Next 3Y5.22%
EPS Next 5Y5.29%
Revenue Next Year6.3%
Revenue Next 2Y5.44%
Revenue Next 3Y4.91%
Revenue Next 5Y4.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELIS.PA Yearly Revenue VS EstimatesELIS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
ELIS.PA Yearly EPS VS EstimatesELIS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.66, which indicates a rather expensive current valuation of ELIS.
ELIS's Price/Earnings ratio is in line with the industry average.
ELIS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
A Price/Forward Earnings ratio of 11.50 indicates a reasonable valuation of ELIS.
Based on the Price/Forward Earnings ratio, ELIS is valued a bit cheaper than the industry average as 69.57% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ELIS is valued a bit cheaper.
Industry RankSector Rank
PE 23.66
Fwd PE 11.5
ELIS.PA Price Earnings VS Forward Price EarningsELIS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELIS indicates a somewhat cheap valuation: ELIS is cheaper than 67.39% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ELIS is valued a bit cheaper than 65.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.39
EV/EBITDA 6.03
ELIS.PA Per share dataELIS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ELIS does not grow enough to justify the current Price/Earnings ratio.
ELIS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)7.85
PEG (5Y)1.05
EPS Next 2Y3.75%
EPS Next 3Y5.22%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.96%, ELIS has a reasonable but not impressive dividend return.
ELIS's Dividend Yield is a higher than the industry average which is at 3.64.
ELIS's Dividend Yield is comparable with the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.96%

5.2 History

The dividend of ELIS decreases each year by -2.69%.
Dividend Growth(5Y)-2.69%
Div Incr Years1
Div Non Decr Years1
ELIS.PA Yearly Dividends per shareELIS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

ELIS pays out 41.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.72%
EPS Next 2Y3.75%
EPS Next 3Y5.22%
ELIS.PA Yearly Income VS Free CF VS DividendELIS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M
ELIS.PA Dividend Payout.ELIS.PA Dividend Payout, showing the Payout Ratio.ELIS.PA Dividend Payout.PayoutRetained Earnings

ELIS SA

EPA:ELIS (3/7/2025, 7:00:00 PM)

22

+0.06 (+0.27%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-05 2025-05-05
Inst Owners50.95%
Inst Owner ChangeN/A
Ins Owners0.43%
Ins Owner ChangeN/A
Market Cap5.21B
Analysts83.16
Price Target25.72 (16.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.96%
Yearly Dividend0.27
Dividend Growth(5Y)-2.69%
DP41.72%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.59%
PT rev (3m)-2.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 23.66
Fwd PE 11.5
P/S 1.17
P/FCF 9.39
P/OCF 3.72
P/B 1.52
P/tB N/A
EV/EBITDA 6.03
EPS(TTM)0.93
EY4.23%
EPS(NY)1.91
Fwd EY8.7%
FCF(TTM)2.34
FCFY10.65%
OCF(TTM)5.91
OCFY26.85%
SpS18.82
BVpS14.48
TBVpS-5.06
PEG (NY)7.85
PEG (5Y)1.05
Profitability
Industry RankSector Rank
ROA 2.64%
ROE 7.09%
ROCE 7.3%
ROIC 4.98%
ROICexc 5.28%
ROICexgc 16.13%
OM 11.47%
PM (TTM) 5.45%
GM 32.81%
FCFM 12.45%
ROA(3y)2.21%
ROA(5y)1.68%
ROE(3y)5.91%
ROE(5y)4.52%
ROIC(3y)3.94%
ROIC(5y)3.44%
ROICexc(3y)4.18%
ROICexc(5y)3.61%
ROICexgc(3y)12.82%
ROICexgc(5y)11.12%
ROCE(3y)5.71%
ROCE(5y)4.96%
ROICexcg growth 3Y48.06%
ROICexcg growth 5Y7.47%
ROICexc growth 3Y42.38%
ROICexc growth 5Y10.63%
OM growth 3Y22.26%
OM growth 5Y5.06%
PM growth 3Y298.56%
PM growth 5Y18.35%
GM growth 3Y3.37%
GM growth 5Y1.99%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 7.6
Debt/EBITDA 2.34
Cap/Depr 90.42%
Cap/Sales 18.94%
Interest Coverage 5.21
Cash Conversion 96.81%
Profit Quality 228.34%
Current Ratio 0.74
Quick Ratio 0.66
Altman-Z 1.31
F-Score6
WACC5.15%
ROIC/WACC0.97
Cap/Depr(3y)86.18%
Cap/Depr(5y)83.92%
Cap/Sales(3y)18.75%
Cap/Sales(5y)18.97%
Profit Quality(3y)240.34%
Profit Quality(5y)2775.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.13%
EPS 3Y363.54%
EPS 5Y22.57%
EPS Q2Q%-13.4%
EPS Next Y3.01%
EPS Next 2Y3.75%
EPS Next 3Y5.22%
EPS Next 5Y5.29%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y15.37%
Revenue growth 5Y6.58%
Sales Q2Q%6.92%
Revenue Next Year6.3%
Revenue Next 2Y5.44%
Revenue Next 3Y4.91%
Revenue Next 5Y4.92%
EBIT growth 1Y1.17%
EBIT growth 3Y41.06%
EBIT growth 5Y11.98%
EBIT Next Year151.42%
EBIT Next 3Y40.57%
EBIT Next 5Y24.16%
FCF growth 1Y77.07%
FCF growth 3Y12.88%
FCF growth 5Y20.33%
OCF growth 1Y46.44%
OCF growth 3Y16.06%
OCF growth 5Y9.21%